Efficacy of a low-dose subcutaneous lisuride infusion in Parkinson's disease

Internal Medicine

Volumn 37, Issue 5, 1998, Pages 444-448

  Hayashi, Ryoichi ^a   Tako, Kenji ^a   Makishita, Hideo ^a   Koyama, Jun ^a   Yanagisawa, Nobuo ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Clinical efficacy; Dopamine agonist; Dyskinesia; Levodopa; Motor fluctuation

Indexed keywords

LEVODOPA; LISURIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE CLASSIFICATION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG URINE LEVEL; DYSKINESIA; FEMALE; HUMAN; MALE; MENTAL DISEASE; ORAL DRUG ADMINISTRATION; PARKINSON DISEASE; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0031816729     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.37.444     Document Type: Article

References (12)

1. Marsden CD, Parkes JD. "On-off" effects in patients with Parkinson's disease on chronic levodopa therapy. Lancet i: 292, 1976.
2. Narabayashi H, Yokochi M, Iizuka R, Nagatsu T. Juvenile parkinsonism. in: Handbook of Clinical Neurology Vol. 5 (49): Extrapyramidal disorders. Vinken PJ, Bruyn GW, Klawans HL, Eds. Elsevier Science Publishers B.V. Amsterdam, 1986, p. 153.
3. Marion MH, Stocchi F, Quinn NP, Jenner P, Marsden CD. Repeated levodopa infusions in fluctuating Parkinson's disease: clinical and pharmacokinetic data. Clin Neuropharmacol 9: 165, 1986.
4. Fabbrini G, Mouradian MM, Juncos JL, Schlegel J, Mohr E, Chase TN. Motor fluctuations in Parkinson's disease: central pathophysiological mechanisms, part I. Ann Neurol 24: 366, 1988.
5. Kurlan R, Rubin AJ, Miller C, Rivera-Calimlim L, Clarke A, Shoulson I. Duodenal delivery of levodopa for on-off fluctuations in parkinsonism: preliminary observations. Ann Neurol 20: 262, 1986.
6. Sage JI, Trooskin S, Sonsalla PK, Heikkila R. Duvoisin RC. Long-term duodenal infusion of levodopa for motor fluctuations in parkinsonism. Ann Neurol 24: 87, 1988.
7. Stibe CMH, Lees AJ, Kempster PA, Stern GM. Subcutaneous apomorphine in parkinsonian on-off oscillations. Lancet i: 403, 1988.
8. Vaamonde J, Luquin MR, Obeso JA. Subcutaneous lisuride infusion in Parkinson's disease: response to chronic administration in 34 patients. Brain 114: 601, 1991.
9. Yanagisawa N, Kowa H, Mizuno Y, et al. Long-term study of lisuride maleate in patients with parkinsonism. Multi-center open study. J Med Pharmaceutical Sci 30: 1472, 1993.
10. Mouradian MM, Juncos JL, Fabbrini G, Schlegel J, Bartko JJ, Chase TN. Motor fluctuations in Parkinson's disease: central pathophysiologic mechanisms, part II. Ann Neurol 24: 372, 1988.
11. Obeso JA, Luquin MR, Vaamonde J, Martinez-Lage JM. Subcutaneous administration of lisuride in the treatment of complex motor fluctuations in Parkinson's disease. J Neural Transm Suppl 27: 17, 1988.
12. Baronti F, Mouradian MM, Davis TL, et al. Continuous lisuride effects on central dopaminergic mechanisms in Parkinson's disease. Ann Neurol 32: 776, 1992.